Frontier Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-246,546
| Closed | -$13.5M | – | 305 |
|
|
2025
Q3 | $13.5M | Buy |
246,546
+28,101
| +13% | +$1.4M | 0.12% | 218 |
|
|
2025
Q2 | $11.6M | Sell |
218,445
-644
| -0.3% | -$32.7K | 0.11% | 232 |
|
|
2025
Q1 | $9.48M | Sell |
219,089
-6,710
| -3% | -$340K | 0.1% | 223 |
|
|
2024
Q4 | $12.7M | Sell |
225,799
-365,411
| -62% | -$22.7M | 0.12% | 203 |
|
|
2024
Q3 | $40.3M | Sell |
591,210
-114,258
| -16% | -$6.45M | 0.38% | 100 |
|
|
2024
Q2 | $29.8M | Buy |
705,468
+49,412
| +8% | +$2.72M | 0.3% | 136 |
|
|
2024
Q1 | $45.3M | Buy |
656,056
+73,835
| +13% | +$4.67M | 0.42% | 83 |
|
|
2023
Q4 | $43.1M | Buy |
582,221
+113,154
| +24% | +$7.42M | 0.44% | 80 |
|
|
2023
Q3 | $32M | Sell |
469,067
-61,067
| -12% | -$5.18M | 0.35% | 113 |
|
|
2023
Q2 | $49.8M | Sell |
530,134
-217,832
| -29% | -$17M | 0.48% | 72 |
|
|
2023
Q1 | $50.7M | Sell |
747,966
-114,129
| -13% | -$7.34M | 0.52% | 72 |
|
|
2022
Q4 | $42.7M | Buy |
862,095
+291,616
| +51% | +$11.9M | 0.46% | 77 |
|
|
2022
Q3 | $18.5M | Buy |
570,479
+41,719
| +8% | +$1.72M | 0.22% | 150 |
|
|
2022
Q2 | $20.8M | Sell |
528,760
-1,197
| -0.2% | -$64K | 0.24% | 148 |
|
|
2022
Q1 | $37.1M | Sell |
529,957
-67,508
| -11% | -$4.93M | 0.34% | 108 |
|
|
2021
Q4 | $46.5M | Sell |
597,465
-29,595
| -5% | -$2.61M | 0.37% | 92 |
|
|
2021
Q3 | $59.9M | Sell |
627,060
-125,260
| -17% | -$13.2M | 0.47% | 71 |
|
|
2021
Q2 | $93.5M | Sell |
752,320
-4,216
| -0.6% | -$503K | 0.69% | 41 |
|
|
2021
Q1 | $99.7M | Sell |
756,536
-397,097
| -34% | -$54.4M | 0.75% | 35 |
|
|
2020
Q4 | $153M | Sell |
1,153,633
-271,000
| -19% | -$32.8M | 1.13% | 11 |
|
|
2020
Q3 | $145M | Sell |
1,424,633
-222,919
| -14% | -$19.3M | 1.27% | 6 |
|
|
2020
Q2 | $143M | Buy |
1,647,552
+421,764
| +34% | +$33.7M | 1.27% | 10 |
|
|
2020
Q1 | $71.1M | Buy |
1,225,788
+192,865
| +19% | +$15.7M | 0.8% | 36 |
|
|
2019
Q4 | $95.5M | Buy |
1,032,923
+183,103
| +22% | +$16.1M | 0.71% | 43 |
|
|
2019
Q3 | $76.8M | Sell |
849,820
-18,636
| -2% | -$2.12M | 0.6% | 49 |
|
|
2019
Q2 | $103M | Sell |
868,456
-119,182
| -12% | -$12M | 0.77% | 34 |
|
|
2019
Q1 | $85.5M | Sell |
987,638
-247,208
| -20% | -$21M | 0.61% | 49 |
|
|
2018
Q4 | $77.9M | Sell |
1,234,846
-351,005
| -22% | -$24.1M | 0.63% | 52 |
|
|
2018
Q3 | $125M | Buy |
1,585,851
+434,184
| +38% | +$28.3M | 0.81% | 27 |
|
|
2018
Q2 | $68.9M | Buy |
1,151,667
+30,376
| +3% | +$1.63M | 0.49% | 70 |
|
|
2018
Q1 | $45.2M | Buy |
1,121,291
+229,212
| +26% | +$11.2M | 0.33% | 119 |
|
|
2017
Q4 | $46.9M | Sell |
892,079
-24,634
| -3% | -$1.32M | 0.34% | 114 |
|
|
2017
Q3 | $43.2M | Buy |
916,713
+568,144
| +163% | +$22.9M | 0.31% | 129 |
|
|
2017
Q2 | $12.3M | Buy |
+348,569
| New | +$10.8M | 0.09% | 226 |
|
Other funds holding EXAS
HI
PCM
FCM
DKCM
Frontier Capital Management's EXAS Position: Q4 2025 in Review
Frontier Capital Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 246,546 shares — an estimated $13.5M sold.
Frontier Capital Management first reported a position in EXAS in Q2 2017 and held it in 34 quarters. The position peaked at $153M in Q4 2020. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.
- Frontier Capital Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
- Frontier Capital Management sold 246,546 Exact Sciences shares in Q4 2025, an estimated $13.5M.
- Frontier Capital Management first reported a position in Exact Sciences in Q2 2017 and held it in 34 quarters.
- Frontier Capital Management's Exact Sciences position peaked at $153M in Q4 2020.
- 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.
Based on Frontier Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.